BA08: An open-label, single-arm, non-randomised, phase 2 trial of cisplatin, methotrexate and vinblastine (CMV) for pure squamous cell cancer of the urinary tract. (2019)
Attributed to:
CANCER: Trials with potential global reach and other challenging trials
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0210785
PubMed Identifier: 30650143
Publication URI: http://europepmc.org/abstract/MED/30650143
Type: Journal Article/Review
Volume: 14
Parent Publication: PloS one
Issue: 1
ISSN: 1932-6203